KEY TAKEAWAY: Via the WSJ: Patients who were encouraged by health coaches to review options and get more involved in choices had 5.3% lower overall medical costs, 12.5% fewer hospital admissions and fewer elective surgeries. Continue reading
Barry Werth, who has written two fine books about the biotech company Vertex,and says the the reason pharma raises prices is simple: “Because they can.”. Continue reading
LA TIMES: The Food and Drug Administration frequently speeds experimental medicines to sale by approving them before scientific evidence shows they work. For a drug called Tarceva, the FDA’s decisions resulted in thousands of lung cancer patients taking a drug that could not help them. Twelve years passed before the agency warned doctors in October that Tarceva only worked for a small number of patients with a rare gene mutation. Continue reading
KEY TAKEAWAY: Investment in DTC promotion shows no signs of slowing; pharma has been steadily increasing expenditure since 2012, and data for the period October 2015 to September 2016 show a rise of 18% on the previous year With the total for this period reaching $6bn, 2016 looks likely to have been a record year. Continue reading
An Altarum Institute survey found that most consumers seek health care information from providers, friends and family, and online searches. Of all information types, consumers are most dissatisfied with health care cost information . This is especially true for lower-income and uninsured consumers.
KEY TAKEAWAY: Rethinking pharma productivity, an article by McKinsey consulting, is full of corporate consulting gibberish and is proof that they really don’t understand the business of our industry is helping people and helping employees help patients. Continue reading
According to an article in JAMA “more than 4 million children would lose health insurance if the ACA is repealed via budget reconciliation, almost 1 million of these are younger than 5 years”. Continue reading